ClinVar Miner

Submissions for variant NM_004304.5(ALK):c.3781G>A (p.Gly1261Ser)

dbSNP: rs759144859
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000811560 SCV000951832 uncertain significance Neuroblastoma, susceptibility to, 3 2020-06-10 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with ALK-related disease. This variant is present in population databases (rs759144859, ExAC 0.009%). This sequence change replaces glycine with serine at codon 1261 of the ALK protein (p.Gly1261Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine.
Ambry Genetics RCV004028733 SCV005021967 uncertain significance Hereditary cancer-predisposing syndrome 2024-02-29 criteria provided, single submitter clinical testing The p.G1261S variant (also known as c.3781G>A), located in coding exon 25 of the ALK gene, results from a G to A substitution at nucleotide position 3781. The glycine at codon 1261 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.